First Trust Advisors LP Bridge Bio Pharma, Inc. Transaction History

First Trust Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.35 - $40.45 $758,853 - $1.12 Million	-27,746 Reduced 15.27%	153,951 $4.76 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $1.44 Million - $2.62 Million	59,791 Added 49.05%	181,697 $7.34 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $1.18 Million - $2.44 Million	-69,595 Reduced 36.34%	121,906 $3.21 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $2.55 Million - $3.45 Million	191,501 New	191,501 $3.29 Million
Q4 2022 Feb 09, 2023	BUY	$6.74 - $11.52 $244,008 - $417,058	36,203 Added 31.2%	152,241 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $921,341 - $1.43 Million	116,038 New	116,038 $1.15 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.